Brain delivery systems via mechanism independent of receptor-mediated endocytosis and adsorptive-mediated endocytosis

Current Pharmaceutical Biotechnology

Volumn 13, Issue 12, 2012, Pages 2349-2354

  Thomsen, Louiza Bohn ^a   Lichota, Jacek ^a   Eskehave, Thomas Navndrup ^a   Linemann, Thomas ^a   Mortensen, Joachim Høg ^a   du Jardin, Kristian Gaarn ^a   Moos, Torben ^a  

^a AALBORG UNIVERSITY   (Denmark)

Author keywords

Blood brain barrier; Endothelium; Gene therapy; Magnetic nanoparticle; Transferrin; Transport

Indexed keywords

ABC TRANSPORTER; AMINO ACID; CELL PENETRATING PEPTIDE; DRUG CARRIER; ENBUCRILATE; GLUCOSE; LIPOSOME; MAGNETIC NANOPARTICLE; MONOCARBOXYLATE TRANSPORTER; POLYSORBATE 80; PURINE; TRANSACTIVATOR PROTEIN;

BLOOD BRAIN BARRIER; BRAIN CAPILLARY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUBILITY; DRUG TRANSPORT; ENDOCYTOSIS; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; LIPOPHILICITY; MAGNETIC FIELD; NONHUMAN; NUTRIENT; PROTEIN EXPRESSION; REVIEW; TRANSCYTOSIS;

ADSORPTION; ANIMALS; BRAIN; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HUMANS; MAGNETIC PHENOMENA; MEMBRANE PROTEINS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 84867696013     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112803341842     Document Type: Review

References (24)

1. Lichota, J.; Skjørringe, T.; Thomsen, L.B.; Moos, T. Macromolecular drug transport into the brain using targeted therapy. J. Neurochem., 2010, 113, 1-13.
2. Pardridge, W.M. Brain drug targeting. Cambridge University Press, UK, 2001.
3. Pardridge, W.M. Drug and gene targeting to the brain with molecular Trojan horses. Nat. Rev. Drug Discov., 2002, 1, 131-139.
4. Jiang, C.; Matsuo, H.; Koyabu, N.; Ohtani H.; Fujimoto H.; Yonemitsu Y.; Kaneda Y.; Narro, M.; Tsuruo, T.; Sawada, Y. Transluminal gene transfer into brain capillary endothelial cells in vivo with HVJ-liposomes. J. Drug Target, 2002, 10, 345-352.
5. Jiang, C.; Koyabu, N.; Yonemitsu, Y.; Shimazoe, T.; Watanabe, S.; Naito, M.; Tsuruo T.; Ohtani, H.; Sawada, Y. In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells. Hum. Gene Ther., 2003, 14, 1181-1191.
6. Stewart, P.A. Endothelial vesicles in the blood-brain barrier: are they related to permeability? Cell Mol. Neurobiol., 2000, 20, 149-163.
7. Westergaard, E.; van Deurs, B.; Brondsted, H.E. Increased vesicular transfer of horseradish peroxidase across cerebral endothelium, evoked by acute hypertension. Acta. Neuropathol., 1979, 37, 141-152.
8. Broadwell, R.D.; Baker-Cairns, B.J.; Friden, P.M.; Oliver, C.; Villegas, J.C. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. Exp. Neurol., 1996, 142, 47-65.
9. Roberts, R.L.; Fine, R.E.; Sandra, A. Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J. Cell Sci., 1993, 104, 521-532.
10. Abbott, N.J.; Patabendige, A.A.; Dolman, D.E.; Yusof, S.R.; Begley, D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis., 2010, 37, 13-25.
11. Gaillard, P.J. Targeted bood-to-brain drug delivery-10 key development criteria. Curr. Pharm. Biotechnol., 2010, in press.
12. Lu, W. Adsorptive-mediated brain delivery systems. Curr. Pharm. Biotechnol., 2010, in press.
13. Pardridge, W.M. CNS drug design based on principles of bloodbrain barrier transport. J. Neurochem., 1998, 70, 781-1792.
14. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Res., 1997, 23, 3-25.
15. Begley, D.J. ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 2004, 10, 1295-1312.
16. Boado, R.J.; Li, J.Y.; Nagaya, M.; Zhang, C.; Pardridge, W.M. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc. Natl. Acad. Sci. USA, 1999, 96, 12079-12084.
17. Nawashiro, H.; Otani, N.; Uozumi, Y.; Ooigawa, H.; Toyooka, T.; Suzuki, T.; Katoh, H.; Tsuzuki, N.; Ohnuki, A.; Shima, K.; Shinomiya, N.; Matsuo, H.; Kanai, Y. High expression of L-type amino acid transporter 1 in infiltrating glioma cells. Brain Tumor Pathol. 2005, 22, 89-91.
18. Dietz, G.P. Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research. Curr. Pharm. Biotechnol. 2010, 11, 167-174.
19. Torchilin, V.P. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers. 2008, 90, 604-610.
20. Chomoucka, J.; Drbohlavova, J.; Huska, D.; Adam, V.; Kizek, R.; Hubalek, J. Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res., 2010, 62(2), 144-149.
21. Namdeo, M.; Saxena, S.; Tankhiwale, R.; Bajpai, M.; Mohan, Y.M.; Bajpai, S.K. Magnetic nanoparticles for drug delivery applications. J. Nanosci. Nanotechnol., 2008, 8, 3247-3271.
22. Zensi, A.; Begley, D.; Pontikis, C.; Legros, C.; Mihoreanu, L.; Wagner, S.; Büchel, C.; von Briesen, H.; Kreuter, J. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J. Control Release, 2009, 137, 78-86.
23. Mailander, V.; Landfester, K. Interaction of nanoparticles with cells. Biomacromolecules, 2009, 10, 2379-2400.
24. Saiyed, Z.M.; Gandhi, N.H.; Nair, M.P. Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier. Int. J. Nanomedicin, 2010, 5, 157-166.